Cargando…

Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer

Immune checkpoint inhibitors (ICIs) have demonstrated efficacy in advanced esophageal squamous cell carcinoma (ESCC). Heterogeneous responses to ICIs have been reported previously. Here, we describe a patient with advanced ESCC exhibiting a response to durvalumab plus tremelimumab for more than 6 mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jhe‐Cyuan, Hsu, Chia‐Lang, Hsieh, Min‐Shu, Lin, Chia‐Chi, Huang, Ta‐Chen, Kuo, Hung‐Yang, Shao, Yu‐Yun, Hsu, Chih‐Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396778/ https://www.ncbi.nlm.nih.gov/pubmed/37340770 http://dx.doi.org/10.1111/1759-7714.14997

Ejemplares similares

B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
por: Guo, Jhe-Cyuan, et al.
Publicado: (2022)

Activation of phagocytosis by immune checkpoint blockade
por: Li, Chia-Wei, et al.
Publicado: (2018)

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma
por: Zhao, Jing-Jing, et al.
Publicado: (2018)

Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy
por: Ebelt, Nancy D., et al.
Publicado: (2020)

The Tumor Immune Contexture of Prostate Cancer
por: Vitkin, Natasha, et al.
Publicado: (2019)

Effects of Hyperthermia and Hyperthermic Intraperitoneal Chemoperfusion on the Peritoneal and Tumor Immune Contexture
por: Chia, Daryl K. A., et al.
Publicado: (2023)

Immuno-Contexture and Immune Checkpoint Molecule Expression in Mismatch Repair Proficient Colorectal Carcinoma
por: Giacomelli, Mauro, et al.
Publicado: (2023)

Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer
por: Chen, Mei‐Chih, et al.
Publicado: (2023)

Data-Driven Discovery of Immune Contexture Biomarkers
por: Schwen, Lars Ole, et al.
Publicado: (2018)

License to kill: microsatellite instability and immune contexture
por: Maby, Pauline, et al.
Publicado: (2021)

The Immune Contexture of Liposarcoma and Its Clinical Implications
por: Resag, Antonia, et al.
Publicado: (2022)

The immune contexture of hepatocellular carcinoma predicts clinical outcome
por: Foerster, Friedrich, et al.
Publicado: (2018)

Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma
por: Gasparini, Patrizia, et al.
Publicado: (2019)

Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response
por: Lin, Chia-Yi, et al.
Publicado: (2023)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic Cancer
por: Wu, Hsu, et al.
Publicado: (2019)

Immune contexture analysis in immuno‐oncology: applications and challenges of multiplex fluorescent immunohistochemistry
por: Shakya, Reshma, et al.
Publicado: (2020)

Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration
por: Jin, Jing, et al.
Publicado: (2020)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017)

Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020)

Neutrophils in the era of immune checkpoint blockade
por: Faget, Julien, et al.
Publicado: (2021)

Reduced FEV(1) as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors
por: Shen, Yi-Luen, et al.
Publicado: (2022)

Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer
por: Wu, Tong, et al.
Publicado: (2019)

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
por: Finotello, Francesca, et al.
Publicado: (2019)

Tumor-infiltrating podoplanin(+) cells in gastric cancer: clinical outcomes and association with immune contexture
por: Liu, Xin, et al.
Publicado: (2020)

Immune Contexture of MMR-Proficient Primary Colorectal Cancer and Matched Liver and Lung Metastases
por: Ahtiainen, Maarit, et al.
Publicado: (2021)

Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases
por: Lu, Benjamin Y, et al.
Publicado: (2021)

High Dimensional Imaging Mass Cytometry Panel to Visualize the Tumor Immune Microenvironment Contexture
por: Elaldi, Roxane, et al.
Publicado: (2021)

Senescence-related genes define prognosis, immune contexture, and pharmacological response in gastric cancer
por: Shen, Xiaogang, et al.
Publicado: (2023)

MCT4 blockade increases the efficacy of immune checkpoint blockade
por: Babl, Nathalie, et al.
Publicado: (2023)

Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression
por: Jin, Jing, et al.
Publicado: (2021)

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
por: Li, Xiaolei, et al.
Publicado: (2018)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

The Puzzle of Predicting Response to Immune Checkpoint Blockade
por: Onyshchenko, Mykola
Publicado: (2018)

Smoldering myocarditis following immune checkpoint blockade
por: Norwood, Timothy G., et al.
Publicado: (2017)

The role of neoantigen in immune checkpoint blockade therapy
por: Yi, Ming, et al.
Publicado: (2018)

Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018)

Acquired Resistance to Immune Checkpoint Blockade Therapies
por: Zhao, Xianda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oick0au5n3qkr6ntpb7cogs3qp